(NASDAQ: ZSQR) Z Squared's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 107.51%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,320.2%.
Z Squared's earnings in 2026 is -$11,768,485.On average, 3 Wall Street analysts forecast ZSQR's earnings for 2026 to be -$8,918,221, with the lowest ZSQR earnings forecast at -$8,568,487, and the highest ZSQR earnings forecast at -$9,180,522.
In 2027, ZSQR is forecast to generate -$9,442,822 in earnings, with the lowest earnings forecast at -$9,072,515 and the highest earnings forecast at -$9,720,552.